These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8992490)

  • 1. Cyclooxygenase and lipoxygenase inhibitors in cancer therapy.
    Ara G; Teicher BA
    Prostaglandins Leukot Essent Fatty Acids; 1996 Jan; 54(1):3-16. PubMed ID: 8992490
    [No Abstract]   [Full Text] [Related]  

  • 2. Interrelationships between prostanoids and skin flap survival: a review.
    Knight KR; Lepore DA; O'Brien BM
    Prostaglandins Leukot Essent Fatty Acids; 1991 Dec; 44(4):195-200. PubMed ID: 1726125
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclooxygenase, lipoxygenase and tumor angiogenesis.
    Nie D; Honn KV
    Cell Mol Life Sci; 2002 May; 59(5):799-807. PubMed ID: 12088280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-LOX inhibition: current evidence for an emerging new therapy.
    Skelly MM; Hawkey CJ
    Int J Clin Pract; 2003 May; 57(4):301-4. PubMed ID: 12800462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arachidonate transforming and immunomodulating agents: unapproved uses or indications.
    Lotti TM; Menchini G; Spallanzani A; Moretti S; Ghersetich I; Bianchi B
    Clin Dermatol; 2000; 18(1):119-23. PubMed ID: 10701093
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of arachidonic acid metabolism and cyclic AMP content of human alveolar macrophages.
    Bachelet M; Chouaid C; Havet N; Masliah J; Barre A; Housset B; Vargaftig BB
    Eicosanoids; 1992; 5(3-4):185-90. PubMed ID: 1337976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy.
    Romano M; Claria J
    FASEB J; 2003 Nov; 17(14):1986-95. PubMed ID: 14597668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective interactions of cyclooxygenase and lipoxygenase metabolites with the cyclic GMP systems in the myometrium.
    Harbon S; Tanfin Z; Leiber D; Vesin MF; DoKhac L
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():639-49. PubMed ID: 6145335
    [No Abstract]   [Full Text] [Related]  

  • 10. DuCLOX-2/5 inhibition: a promising target for cancer chemoprevention.
    Gautam S; Roy S; Ansari MN; Saeedan AS; Saraf SA; Kaithwas G
    Breast Cancer; 2017 Mar; 24(2):180-190. PubMed ID: 27558792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the cyclooxygenase/lipoxygenase pathways to improve interferon alfa efficacy in chronic hepatitis C: a wrong track.
    Bastie A; Castera L; Roudot-Thoraval F; Dhumeaux D; Pawlotsky JM
    Hepatology; 2000 Feb; 31(2):547-8. PubMed ID: 10691381
    [No Abstract]   [Full Text] [Related]  

  • 12. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
    Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
    Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional and botanical modulation of the inflammatory cascade--eicosanoids, cyclooxygenases, and lipoxygenases--as an adjunct in cancer therapy.
    Wallace JM
    Integr Cancer Ther; 2002 Mar; 1(1):7-37; discussion 37. PubMed ID: 14664746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anti-inflammatory potential of fixed oil of Ocimum sanctum (Holybasil) and its possible mechanism of action.
    Singh S; Majumdar DK; Rehan HM
    J Ethnopharmacol; 1996 Oct; 54(1):19-26. PubMed ID: 8941864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of skin tumor promotion by inhibitors of arachidonic acid metabolism.
    Fischer SM; Mills GD; Slaga TJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():309-12. PubMed ID: 6221608
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of cell-substrate adhesion by the lipoxygenase and cyclooxygenase branches of arachidonic acid metabolism.
    Roberts LA; Glenn HL; Whitfield RA; Jacobson BS
    Adv Exp Med Biol; 2002; 507():525-9. PubMed ID: 12664635
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs.
    Martel-Pelletier J; Lajeunesse D; Reboul P; Pelletier JP
    Ann Rheum Dis; 2003 Jun; 62(6):501-9. PubMed ID: 12759283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitors for enzymes involving arachidonate cascade].
    Nakashima S; Nozawa Y
    Nihon Rinsho; 1991 Sep; 49(9):1984-92. PubMed ID: 1960866
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery of Novel 15-Lipoxygenase Activators To Shift the Human Arachidonic Acid Metabolic Network toward Inflammation Resolution.
    Meng H; McClendon CL; Dai Z; Li K; Zhang X; He S; Shang E; Liu Y; Lai L
    J Med Chem; 2016 May; 59(9):4202-9. PubMed ID: 26290290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclooxygenases, lipoxygenases, their targeted drugs and the prevention of Alzheimer's disease].
    Shen JN; Xu LX; Wang R
    Yao Xue Xue Bao; 2013 Dec; 48(12):1743-54. PubMed ID: 24689230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.